Learn about Erythema Multiforme (EM), including EM Major and EM Minor, diagnosis, clinical documentation, and medical coding. Find information on Erythema Multiforme symptoms, causes, treatment, and ICD-10 codes for accurate healthcare records and billing. This resource provides essential guidance for clinicians and healthcare professionals on properly documenting and coding EM in medical settings.
Also known as
Erythema multiforme
Inflammatory skin disorder with target lesions.
Diseases of the skin and subcutaneous tissue
Includes various skin conditions like infections, inflammation, and ulcers.
Rash and other nonspecific skin eruption
Covers unspecified skin rashes when a more precise diagnosis isn't available.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the Erythema Multiforme (EM) drug-induced?
When to use each related code
| Description |
|---|
| Acute, immune-mediated skin reaction. |
| Severe mucocutaneous reaction with epidermal detachment. |
| Mild form of Erythema Multiforme. |
Incorrectly coding EM Major as EM Minor or vice versa, impacting reimbursement and quality metrics. CDI crucial for specificity.
Lack of documentation linking EM to underlying cause (e.g., HSV, medication) leads to coding and billing errors. Crucial for medical necessity.
Misdiagnosing overlapping SJS/TEN as EM, leading to incorrect, lower severity coding and affecting quality reporting and outcomes analysis.
Q: How can I differentiate between erythema multiforme minor and erythema multiforme major (Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis overlap) in my clinical practice?
A: Differentiating erythema multiforme (EM) minor from EM major, which represents the milder end of the Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) spectrum, requires careful assessment of mucosal involvement and skin detachment. EM minor typically presents with target lesions and limited or no mucosal involvement. While oral lesions may occur, they are usually mild. In contrast, EM major involves more widespread and severe mucosal erosions affecting at least two mucosal sites (e.g., oral, ocular, genital). Additionally, EM major exhibits epidermal detachment affecting less than 10% of the body surface area (BSA). Skin biopsies can be helpful in ambiguous cases. Explore how histopathological findings can further aid in distinguishing these conditions. Consider implementing a standardized skin assessment protocol in your practice to accurately document the extent of skin and mucosal involvement for appropriate diagnosis and management.
Q: What are the most common drug triggers for erythema multiforme, and how should I approach medication management in a patient with suspected drug-induced EM?
A: Several medications are commonly implicated in erythema multiforme (EM) reactions. These include sulfonamides, anticonvulsants (e.g., phenytoin, carbamazepine, lamotrigine), nonsteroidal anti-inflammatory drugs (NSAIDs), allopurinol, and certain antibiotics (e.g., penicillins, cephalosporins). If drug-induced EM is suspected, the offending medication should be immediately discontinued. A thorough medication history is crucial. Learn more about the Naranjo Algorithm and other causality assessment tools to help determine the likelihood of a drug being the causative agent. If the patient requires alternative medications for their underlying condition, careful consideration should be given to potential cross-reactivity within drug classes. Consider implementing a phased reintroduction of medications under close observation when necessary.
Patient presents with symptoms consistent with Erythema Multiforme (EM), likely EM minor. Onset of the rash was reported as [duration] ago, characterized by [description of lesions - e.g., well-defined, erythematous target lesions, macules, papules, vesicles, bullae] distributed on [location of lesions - e.g., extremities, palms, soles, oral mucosa]. Patient denies fever, malaise, or systemic symptoms. Lesions are [description of discomfort - e.g., pruritic, painful, burning]. No mucosal involvement noted. Patient reports [possible triggering factor - e.g., recent herpes simplex virus infection, medication exposure, Mycoplasma pneumoniae infection]. Differential diagnoses considered include Stevens-Johnson Syndrome, toxic epidermal necrolysis, drug eruption, and urticaria. Based on clinical presentation and history, the diagnosis of Erythema Multiforme minor is favored. Treatment plan includes [treatment - e.g., symptomatic management with antihistamines, topical corticosteroids, discontinuation of suspected causative medication]. Patient education provided regarding EM prognosis, recurrence prevention, and potential complications. Follow-up scheduled in [duration] to monitor resolution and assess for any progression of symptoms. ICD-10-CM code L51.1 (Erythema multiforme) is assigned.